Published in Vaccine Weekly, October 18th, 1999
F. Poltl-Frank and colleagues, Swiss Tropical Institute, Basel, Switzerland, used immunopotentiating reconstituted influenza virosomes (IRIV) as a delivery system for the synthetic peptide-based malaria vaccine SPf66 ("Use of Reconstituted Influenza Virus Virosomes As an Immunopotentiating Delivery System for a Peptide-Based Vaccine," Clin Exp Immunol, September 1999;117(3):496-503).
The reduced SPf66 peptide molecules containing terminal cysteine residues were covalently attached to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly